Geron Corporation Profile Avatar - Palmy Investing

Geron Corporation

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, …

Biotechnology
US, Foster City [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Geron Corporation has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Geron Corporation can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Geron Corporation.

End of GERN's Analysis
CIK: 886744 CUSIP: 374163103 ISIN: US3741631036 LEI: - UEI: -
Secondary Listings
GERN has no secondary listings inside our databases.